Matt Larew Analyst PerformancePartner at William BlairMatt Larew is a stock analyst at William Blair in the medical sector, covering 9 publicly traded companies. Over the past year, Matt Larew has issued 6 stock ratings, including buy and hold recommendations. While full access to Matt Larew's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matt Larew's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings12 Last 8 YearsBuy Recommendations66.67% 8 Buy RatingsCompanies Covered9 Unique Companies Ratings Distribution12RatingsDistribution of strong buy, buy, hold, and sell ratings by Matt Larew.RatingPercentageCount Strong Buy0.0%0 ratings Buy66.7%8 ratings Hold33.3%4 ratings Sell0.0%0 ratingsOut of 12 total stock ratings issued by Matt Larew at William Blair, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.Best & Worst CallsBest Call000.0%DVAJun 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%DVAJun 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE66.7% of companies on NYSE6 companiesNASDAQ33.3% of companies on NASDAQ3 companiesMatt Larew, an analyst at William Blair, currently covers 9 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical9 companies100.0%Matt Larew of William Blair specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE2 companies22.2%MED INSTRUMENTS2 companies22.2%MEDICAL SERVICES2 companies22.2%MED - OUTP/HM CRE2 companies22.2%MEDICAL INFO SYS1 company11.1% Matt Larew's Ratings History at William Blair Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTECHBio-Techne6/25/2026Downgrade$70.70Market Perform$0.0000.00% ROITXG10x Genomics3/31/2026Upgrade$19.81Outperform$0.0000.00% ROIWATWaters1/5/2026Initiated Coverage$381.97Outperform$0.0000.00% ROICRLCharles River Laboratories International10/6/2025Upgrade$177.56Outperform$0.0000.00% ROITMOThermo Fisher Scientific8/18/2025Initiated Coverage$488.15Outperform$0.0000.00% ROIMXCTMaxCyte8/7/2025Downgrade$2.04Market Perform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialRaymond James FinancialStifel NicolausBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
